163 related articles for article (PubMed ID: 23593581)
1. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
Aswar UM; Kalshetti PP; Shelke SM; Bhosale SH; Bodhankar SL
Asian Pac J Trop Biomed; 2012 Dec; 2(12):992-8. PubMed ID: 23593581
[TBL] [Abstract][Full Text] [Related]
2. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
[TBL] [Abstract][Full Text] [Related]
3. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
Breuer ME; van Gaalen MM; Wernet W; Claessens SE; Oosting RS; Behl B; Korte SM; Schoemaker H; Gross G; Olivier B; Groenink L
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):101-6. PubMed ID: 18668225
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B
Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants.
Takahashi K; Saitoh A; Yamada M; Maruyama Y; Hirose N; Kamei J; Yamada M
J Pharmacol Sci; 2008 Nov; 108(3):320-34. PubMed ID: 19023179
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabolic disturbance in the olfactory bulbectomized rats and the modulatory effects of fluoxetine.
Zhou YF; Feng L; Liu XM; Tao X; Wang LS; Zhang MD; Wang Z; Chen SG; Chang Q
Life Sci; 2019 Oct; 234():116751. PubMed ID: 31415771
[TBL] [Abstract][Full Text] [Related]
8. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.
Breuer ME; Chan JS; Oosting RS; Groenink L; Korte SM; Campbell U; Schreiber R; Hanania T; Snoeren EM; Waldinger M; Olivier B
Eur Neuropsychopharmacol; 2008 Dec; 18(12):908-16. PubMed ID: 18789657
[TBL] [Abstract][Full Text] [Related]
9. The olfactory bulbectomized rat as a model of depression: an update.
Kelly JP; Wrynn AS; Leonard BE
Pharmacol Ther; 1997; 74(3):299-316. PubMed ID: 9352586
[TBL] [Abstract][Full Text] [Related]
10. Hippocampus Metabolic Disturbance and Autophagy Deficiency in Olfactory Bulbectomized Rats and the Modulatory Effect of Fluoxetine.
Zhou Y; Tao X; Wang Z; Feng L; Wang L; Liu X; Pan R; Liao Y; Chang Q
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480539
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
12. The olfactory bulbectomized rat model is not an appropriate model for studying depression based on morphological/stereological studies of the hippocampus.
Yurttas C; Schmitz C; Turgut M; Strekalova T; Steinbusch HWM
Brain Res Bull; 2017 Sep; 134():128-135. PubMed ID: 28734903
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinus officinalis L. hydroalcoholic extract, similar to fluoxetine, reverses depressive-like behavior without altering learning deficit in olfactory bulbectomized mice.
Machado DG; Cunha MP; Neis VB; Balen GO; Colla AR; Grando J; Brocardo PS; Bettio LE; Dalmarco JB; Rial D; Prediger RD; Pizzolatti MG; Rodrigues AL
J Ethnopharmacol; 2012 Aug; 143(1):158-69. PubMed ID: 22721880
[TBL] [Abstract][Full Text] [Related]
14. Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats.
Kalshetti PB; Alluri R; Mohan V; Thakurdesai PA
Pharmacogn Mag; 2015 Oct; 11(Suppl 3):S388-96. PubMed ID: 26929572
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety.
Mar A; Spreekmeester E; Rochford J
Pharmacol Biochem Behav; 2002 Oct; 73(3):703-12. PubMed ID: 12151047
[TBL] [Abstract][Full Text] [Related]
16. Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.
Padilla KM; Quintanar-Setephano A; López-Vallejo F; Berumen LC; Miledi R; García-Alcocer G
Brain Behav; 2018 May; 8(5):e00952. PubMed ID: 29761007
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects of salidroside on olfactory bulbectomy-induced pro-inflammatory cytokine production and hyperactivity of HPA axis in rats.
Yang SJ; Yu HY; Kang DY; Ma ZQ; Qu R; Fu Q; Ma SP
Pharmacol Biochem Behav; 2014 Sep; 124():451-7. PubMed ID: 25101546
[TBL] [Abstract][Full Text] [Related]
18. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.
Bansal Y; Singh R; Saroj P; Sodhi RK; Kuhad A
Toxicol Appl Pharmacol; 2018 Sep; 355():257-268. PubMed ID: 30017640
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways.
Holzmann I; da Silva LM; Corrêa da Silva JA; Steimbach VM; de Souza MM
Pharmacol Biochem Behav; 2015 Sep; 136():55-63. PubMed ID: 26196245
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.
Jarosik J; Legutko B; Unsicker K; von Bohlen Und Halbach O
Exp Neurol; 2007 Mar; 204(1):20-8. PubMed ID: 17059819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
